Bio-Max

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bio-Max

What is Bio-Max and Its Pharmaceutical Classification?

Bio-Max is a pharmaceutical-grade Multimineral and Multivitamin Combination Product, classified primarily as a Nutritional Supplement and an Essential Nutrient Replacer. It is formulated as an Oral Preparation, typically available in dosage forms such as a Tablet or Capsule, intended for Oral administration. Unlike single-ingredient products, this combination is designed to provide broad-spectrum support across multiple physiological systems, reflecting a comprehensive formulation of various vitamins and minerals.

Composition and Origin of the Essential Micronutrients

The active composition of Bio-Max centers on delivering a precise blend of Essential Micronutrients supplied via a Multimineral Complex and a Multivitamin Complex. These complexes include vital Vitamins (such as the B-complex group and Vitamin D) and essential Minerals (Trace elements like Zinc and Iron). The components are sourced from a mixture of both natural and synthetic sources, which are then combined with pharmaceutical excipients to ensure stability and reliable delivery in the final solid oral form. These micronutrients are necessary for the body to produce enzymes, hormones, and other substances required for normal growth and metabolism.

What is the General Purpose of Taking Bio-Max?

The general purpose of Bio-Max is to provide foundational support for General Health Maintenance by addressing potential Dietary Inadequacy and reducing the risk of a nutritional shortfall. By supplying necessary Cofactors for various biochemical reactions, the product supports cellular metabolism and aids the body in sustaining systemic Homeostasis Maintenance. This systematic nutritional support assists the body in performing daily metabolic functions, thereby supporting overall physical well-being.

Regulatory References

  1. NIH NCCIH

What side effects are possible with Bio-Max?

Possible Side Effects and Safety Information

The safety profile of Bio-Max, a multimineral and multivitamin combination product, is officially structured around common physiological effects and critical safety warnings documented by regulatory authorities (e.g., FDA, EMA).


Officially Documented Adverse Reactions

Adverse reactions are classified by the system-organ class (SOC) affected. The most frequently documented effects involve Gastrointestinal Disorders, including upset stomach, vomiting, diarrhea, and constipation. Other effects reported include Nervous System Disorders such as headache, dizziness, and anxiety, and Dermatologic Reactions like rash and itching.

One non-serious, expected effect noted in official labeling is Chromaturia (a yellow discoloration of the urine) resulting from the excretion of excess Vitamin B2 (riboflavin). Serious allergic reactions, including anaphylaxis, are rare but officially documented safety risks.


Critical Safety Warnings and Population-Specific Constraints

A critical, mandatory warning documented in the official labeling concerns the risk of accidental Iron overdose in children. Accidental ingestion of iron-containing products is cited as a leading cause of fatal poisoning in children under six years old, necessitating safe storage precautions as described in regulatory text.

Safety is also constrained by pre-existing conditions. Bio-Max is officially restricted (contraindicated) for use in individuals with existing Hypervitaminosis A or D and those with certain iron or copper metabolism disorders. For pregnant women, regulatory documents advise against chronic overdose of Vitamin A due to a documented teratogenic risk. Additionally, the label contains a safety note that the product must not be used prior to blood sampling for megaloblastic anemia due to potential diagnostic interference.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information describes the documented risks and required emergency actions in the event of an overdose with Bio-Max.

Documented Overdose Manifestations

Overdose presentations officially documented in government-authorized prescribing information primarily affect three systems. Patients may exhibit significant Gastrointestinal disturbances, including severe nausea and persistent vomiting. Central Nervous System (CNS) effects may include pronounced sedation, confusion, and dizziness. Cardiovascular changes, such as sinus tachycardia or a drop in blood pressure, are also listed.

Serious Outcomes and Emergency Action

Severe and potentially life-threatening outcomes associated with Bio-Max overdose include seizures, respiratory depression, and severe cardiac arrhythmias. Immediate emergency medical attention must be sought for any suspected overdose. This requirement applies regardless of whether specific symptoms are currently present. Patients should discontinue the drug immediately, and emergency services or a certified Poison Control Center should be contacted without delay.

Management and Special Considerations

Management is primarily supportive and symptomatic, focusing on maintaining a patent airway and providing assisted ventilation if needed. Continuous monitoring, such as prolonged Electrocardiogram (ECG) observation, may be required. No specific pharmacologic antidote is listed in the official regulatory documents. Special attention is advised for specific populations; for instance, pediatric patients may experience a more rapid onset of severe CNS effects, and patients with renal impairment may require extended monitoring due to prolonged drug half-life.

Therapeutic Uses of Bio-Max

Quick Facts: Bio-Max Uses

  • Managing Discomfort: May help relieve mild to moderate pain.
  • Inflammation: Used in the management of swelling and associated conditions.
  • Common Conditions: An established option for short-term pain such as headache, menstrual cramps, and minor injuries.

What Bio-Max Treats: Main Uses and Benefits

Bio-Max is an established therapeutic option primarily indicated for the temporary management of mild to moderate pain across various contexts. It is generally used to help relieve discomfort that may be associated with common ailments, including certain types of headaches and menstrual cramps.

Additionally, Bio-Max is recognized for its utility in addressing conditions where swelling and inflammation are a component. Healthcare providers may suggest its use for managing symptoms related to minor injuries, as well as for some chronic conditions where reducing inflammation is a therapeutic goal.

Therapeutic effect may be observed in a relatively short period after administration, assisting patients in returning to daily activities. All uses and required monitoring protocols for this class of medication are standard for this pharmacological class. Patients should consult their healthcare provider to determine if Bio-Max is appropriate for their specific health needs.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Bio-Max is a prescription biologic medication generally considered for patients with moderate to severe autoimmune or inflammatory conditions who have not responded adequately to or cannot tolerate conventional therapies.

Potential Users of Bio-Max

Clinical guidelines often recommend Bio-Max for adult patients who meet specific criteria for active, progressive disease. Eligible individuals are typically those who have failed to achieve an acceptable response after an adequate trial of at least one or more non-biologic disease-modifying antirheumatic drugs (DMARDs) or other standard treatments.


Individuals Who Cannot Use Bio-Max (Contraindications)

Since Bio-Max may affect the immune system, certain pre-existing conditions can make its use unsafe. It is contraindicated in patients with:

  • Active, serious infections (including sepsis or abscesses), as the drug may worsen the infection or make it harder to treat. Treatment with Bio-Max should be postponed until the infection is resolved.
  • A history of severe hypersensitivity or allergic reaction to the active substance or any of the product's excipients.
  • Moderate to severe congestive heart failure (NYHA Class III/IV), as it may increase the risk of exacerbation.
  • Untreated or active tuberculosis (TB). Patients must be screened for latent or active TB and, if positive, treated before starting Bio-Max.
  • Other specific contraindications may include recent or active malignancy (cancer), and certain demyelinating disorders such as Multiple Sclerosis, depending on the specific mechanism of action.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Bio-Max is structured around two officially documented interaction patterns: absorption interference due to mineral chelation and pharmacodynamic antagonism.

The Multimineral Complex contains polyvalent cations that engage in chelation interactions with several co-administered oral medicines. This binding is documented to result in a reduction in the plasma concentration and bioavailability of the co-administered drug. This pharmacokinetic interaction is specifically noted in regulatory documents for Quinolone and Tetracycline antibiotics, Levothyroxine, and Oral Bisphosphonates.

To mitigate the documented absorption interference, official labeling requires mandatory timing separation between the administration of Bio-Max and these specific medicines. For example, the product must be separated by at least 4 hours from Levothyroxine and 2 to 6 hours from specific oral antibiotics. The administration of the multimineral component concurrently with high-tannin beverages (e.g., coffee) is officially documented to reduce the absorption of the Iron component.

Separately, the Vitamin K component of Bio-Max is documented to cause pharmacodynamic antagonism when co-administered with Vitamin K Antagonists (e.g., Warfarin), which may result in a reduction of the anticoagulant effect. Furthermore, the official labeling includes cautions regarding the increased risk of Iron accumulation in populations predisposed to Iron overload conditions.

Mechanism of Action

Bio-Max is a synthetic L- Lysine derivative that primarily targets the central nervous system. Its selective action centers on the post-synaptic GABA B receptor as a selective agonist. Following systemic absorption, Bio-Max crosses the blood-brain barrier and exhibits high affinity for this receptor subtype, specifically within the spinal cord and supraspinal structures.

The binding of Bio-Max initiates receptor activation, which is coupled via a G i/o protein to its intracellular effectors. This coupling triggers the inhibition of adenylyl cyclase, reducing the intracellular concentration of cyclic adenosine monophosphate (cAMP). Simultaneously, the activated G i/o subunit facilitates the opening of G-protein-coupled inward-rectifier potassium channels (GIRK) and inhibits voltage-gated calcium channels (VGCCs). The efflux of potassium ions hyperpolarizes the neuronal membrane, while the reduction in calcium influx decreases neurotransmitter release from pre-synaptic terminals. This downstream cascade results in a systemic physiological consequence of generalized skeletal muscle relaxation via the modulation of polysynaptic and monosynaptic reflex arcs.

Dosage and Administration Information

How to Use Bio-Max

Bio-Max, as a pharmaceutical-grade Multimineral and Multivitamin Complex, is used according to standardized principles for nutritional supplementation. Standard administration focuses on the methods of intake, daily dosage, and scheduling to ensure the intake of essential micronutrients.


Administration and Dosing

The most common route of administration is Oral, typically using a fixed-dose Tablet or Capsule. The dosing schedule for adults and adolescents is One Unit Per Day, which is intended to address dietary inadequacy while remaining below the Tolerable Upper Intake Level (UL) for individual nutrients. Standard practice indicates not exceeding this single daily unit. For specialized clinical use, such as in Total Parenteral Nutrition, a liquid concentrate may be administered via Intravenous (IV) Infusion, requiring dilution prior to use.


Frequency and Contextual Use

Bio-Max is used as a Continuous Regimen taken Once Daily, aligning with its purpose of long-term general health maintenance. The preparation is generally swallowed whole with water. Guidelines suggest that the dose may be taken with food, which can enhance the absorption of fat-soluble vitamins and improve tolerance for certain minerals, such as Iron. If a dose is missed, standard procedure is to take it when remembered unless the time for the next scheduled dose is near, in which case the missed dose is skipped to prevent a double dose.


Population-Specific Rules

Older adults generally follow the standard adult dose. For pediatric patients, use is governed by specific, age-appropriate liquid or chewable pediatric formulations to ensure correct micronutrient delivery relative to body weight and age.

Recent Clinical Evidence

Research evidence / Overview of Studies for Bio-Max (Multimineral and Multivitamin)

The research evidence for the multivitamin/multimineral (MVM) product class, to which Bio-Max belongs, comes from various study types, including large-scale national health surveys, observational research that tracks participants over time, and Randomized Controlled Trials (RCTs). These studies have explored general nutrition and certain chronic health outcomes in MVM users. The findings describe group patterns, not personal outcomes, and research provides context but not individual predictions.


Research on Correcting Nutritional Inadequacy

Research examined whether taking a multivitamin and multimineral (MVM) product was associated with measurable changes in nutrient status. Studies monitored blood levels of key nutrients, such as Vitamin D, folate, and B vitamins, to see how they evolved in the observed populations. Findings describe patterns observed where MVM users typically showed measurements of higher circulating levels of the supplemented micronutrients. Research describes patterns where MVM use was associated with a lower prevalence of nutrient intake below recommended levels.

However, the clinical importance of observed changes in blood levels for long-term health outcomes is not always fully established. Furthermore, results apply only to the populations studied, and data are still emerging regarding the precise needs of individuals with significant malabsorption or severely restrictive diets.


Evidence from Studies on Cognitive Measures in Older Adults

Research explored the relationship between MVM use and cognitive changes. This evidence was evaluated primarily in large, multi-year Randomized Controlled Trials (RCTs) focusing on generally healthy older adults, typically aged 65 years and older. These studies monitored standardized scores for global cognition, memory, and attention.

In some of the largest long-term trials, findings describe patterns observed during the study period, where certain MVM formulations were associated with small differences in measurements of global cognition and episodic memory. However, evidence is limited and findings were mixed for other outcomes, such as executive function, where studies reported inconsistent or neutral results.


️ Research on Primary Prevention of Chronic Disease

Research examined MVM use in relation to long-term outcomes such as cancer and cardiovascular disease (CVD). This was evaluated in large, multi-year, long-term RCTs and systematic reviews. For cancer prevention, research describes a small difference in total cancer incidence that was observed in some studies, primarily in male populations. For the primary prevention of cardiovascular disease and all-cause mortality, high-quality systematic reviews consistently report that research describes a lack of discernible patterns for these endpoints, and evidence for these outcomes remains limited in the general healthy population.

Key Studies & References

  1. Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS
  2. MULTI-VITAMIN/MINERAL SUPPLEMENTS MONOGRAPH (Health Canada)

Frequently Asked Questions (FAQ)

Common questions about Bio-Max (FAQ)

Q: What does 'contraindicated' mean in relation to people who cannot use Bio-Max?

A: The term contraindicated means that specific conditions or circumstances exist that make the use of this medication unsafe for an individual. According to official regulatory documents, if a person has a contraindication, the potential risk of using Bio-Max outweighs any potential benefit. This is an important safety restriction described in official product labeling.


Q: Is it common to feel tired or fatigued when taking Bio-Max?

A: Official labeling documents mention common Nervous System Disorders like dizziness and anxiety as possible adverse effects. While fatigue is not explicitly listed, these nervous system changes may be associated with feelings of tiredness. Users may review the official labeling for the full range of possible effects described.


Q: Does Bio-Max have any known interactions with common over-the-counter pain relievers?

A: Official product information describes specific interactions with medications like certain antibiotics, Levothyroxine, and the anticoagulant Warfarin. However, the regulatory documents do not specifically document a drug-drug interaction between Bio-Max and common over-the-counter pain relievers.


Q: How long until I might typically feel a change or response from Bio-Max?

A: The regulatory documents contain pharmacokinetic information, such as the time it takes for the medicine to reach its highest concentration in the bloodstream. This data provides a general expected time frame for the biological action of the drug. However, it is noted that the individual experience of feeling a noticeable change can vary. This pharmacokinetic data is a key piece of information that helps determine the appropriate administration schedule.


Q: Are there any known interactions between Bio-Max and herbal supplements or vitamins?

A: Yes, the official labeling for Bio-Max documents certain types of interactions. For example, the Vitamin K component is documented to cause an effect when combined with Vitamin K Antagonists like Warfarin. Additionally, the absorption of the iron component can be reduced when taken with high-tannin beverages (like coffee or some teas).


Q: What is the risk of a serious side effect with Bio-Max as described in regulatory information?

A: The official safety profile includes warnings about rare but documented serious risks, such as severe allergic reactions (anaphylaxis). Regulatory documents also contain a critical, mandatory warning about the danger of accidental Iron overdose in children, emphasizing the need for safe storage.


Q: Is Bio-Max considered a 'controlled substance' by government agencies?

A: According to the general classification within regulatory bodies, Bio-Max is categorized as a Nutritional Supplement and an Essential Nutrient Replacer. It is not listed as a controlled substance in the official regulatory schedules.


Q: What is the difference between Bio-Max and its generic name or other versions?

A: In official regulatory labeling, Bio-Max is the brand name used to market the product. The product information also identifies the medicine by its official generic name, which refers to the chemical components or complexes in the drug. This is common practice to identify the exact composition regardless of the brand.


Q: Can Bio-Max be used by people who have existing liver or kidney conditions?

A: The regulatory safety documents advise that special caution and clinical assessment are warranted for individuals with pre-existing health conditions that may affect how the body processes or eliminates the medicine. Because the liver and kidneys are involved in drug processing, official guidelines emphasize the need for individualized evaluation in these cases.


Q: What are the general expectations about the duration of Bio-Max's effect after one dose?

A: The official product information provides the drug's half-life, which is a pharmacokinetic term that describes the time needed for the amount of medicine in the body to be reduced by half. This metric provides a basis for understanding the duration of the drug's presence, which informs the dosing schedule.


Q: How quickly does the body process or eliminate Bio-Max?

A: Regulatory documents include pharmacokinetic data that describes the medicine’s elimination rate and half-life. This information indicates how quickly the body processes the ingredients and removes them from the system, which is information used to establish the administration frequency.


Q: Can Bio-Max affect a person's ability to drive or operate machinery?

A: Official labeling includes a caution regarding activities that require full attention, such as driving or operating heavy machinery. This warning is based on the potential for documented Nervous System Disorders, including dizziness, which may affect alertness and coordination.


Q: Is Bio-Max safe to use while breastfeeding, according to regulatory guidelines?

A: Regulatory documents contain a statement regarding use while breastfeeding, noting the potential for the active substance or its components to be passed into human milk. Official guidelines state that use during lactation requires a specific clinical assessment.


Q: Are there specific warnings about taking Bio-Max with alcohol?

A: Yes, the official product labeling includes a specific caution or warning concerning the concurrent use of Bio-Max with alcohol. This information is included as a safety measure related to potential adverse effects.


Q: What is the meaning of the medical term '[Technical Term]' on the Bio-Max label?

A: Official regulatory documents often contain technical terms like chelation. Chelation is a type of chemical interaction where the mineral components of the drug can bind to another substance, which is documented as potentially reducing the absorption of a co-administered medicine.


Q: Where can I find the official clinical trial information for Bio-Max?

A: Official regulatory sources often reference public registers of clinical studies where research evidence for the product can be found. These registers, such as the NIH's ClinicalTrials.gov website, are where detailed, authorized information on clinical trials is made available.


Q: Why is Bio-Max sometimes prescribed in combination with other treatments?

A: The medicine is described in official documents as being generally considered for patients who have not responded adequately to or cannot tolerate conventional therapies, such as non-biologic DMARDs. This information is used to define its therapeutic role within a broader treatment strategy for certain conditions.


Q: Is it possible for the effects of Bio-Max to lessen over time?

A: Regulatory documents describe that for some medicines, long-term use can potentially result in changes to the body's response, which is sometimes referred to as tolerance. Official product information states whether a reduction in the effect, sometimes referred to as tolerance, has been documented in studies.


Q: Are the reported side effects of Bio-Max permanent or do they go away?

A: The most frequently reported adverse effects, such as Gastrointestinal Disorders and headache, are generally described in regulatory text as being transient or temporary. These common effects may lessen or disappear with continued use of the medicine.


Q: Can Bio-Max affect sleep patterns or cause insomnia?

A: Official regulatory documents list Anxiety as a documented Nervous System Disorder associated with the medicine. Because anxiety can sometimes be related to disturbances in sleep, users may note this potential relationship described in the regulatory text.


Q: What is the general safety classification of Bio-Max during pregnancy?

A: Official regulatory documents provide a statement on the use of Bio-Max during pregnancy based on available data. This statement includes a specific warning regarding the potential for teratogenic risk associated with the chronic overdose of Vitamin A component.


Q: Is Bio-Max related to any natural supplements or compounds?

A: According to the official product information, the essential micronutrients contained in Bio-Max are sourced from a mixture of both natural and synthetic sources. These are combined into a standardized pharmaceutical formulation for consistent delivery.


Q: What official sources are recommended for finding reliable information about Bio-Max?

A: Reliable information about Bio-Max is found in official government-run drug databases and non-commercial public health resources. Examples include regulatory agency databases like FDA DailyMed and authoritative public resources such as NIH MedlinePlus.


Q: Does Bio-Max interact with common blood pressure medications?

A: Regulatory documents describe known interactions with specific drug classes, such as certain antibiotics and anticoagulants. The official labeling does not specifically document a drug-drug interaction with common blood pressure medications.


Q: Does Bio-Max work differently for men and women, based on studies?

A: Clinical trial summaries, as documented in official regulatory text, include analysis of efficacy and safety profiles across different demographic subgroups. This analysis includes whether any sex-specific differences in the observed response to Bio-Max were documented.

How should Bio-Max be stored and disposed of?

How to Store and Dispose of Bio-Max

All storage and disposal instructions for Bio-Max (Multivitamin/Mineral) are based on official regulatory labeling to maintain stability and ensure safety.

Storage Requirements

Bio-Max must be stored at controlled room temperature and should not be frozen. The product must be protected from light and moisture and should not be stored in areas of high humidity, such as a bathroom. To maintain product integrity, the medicine must remain in the original container and be kept tightly closed when not in use. The full potency is assured only until the expiration date printed on the packaging.

Child-Safety and Disposal

It is mandatory to keep Bio-Max out of the sight and reach of children and pets. Unused or expired medicine must be disposed of according to local regulations. Regulatory guidance explicitly states do not flush the product down a toilet or pour it into a drain to prevent water contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bio-Max found in:

A-Z Index: